Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes

Journal of General Virology

Volumn 95, Issue PART 4, 2014, Pages 968-979

  van der Sluis, Renée M ^a   Derking, Ronald ^a   Breidel, Seyguerney ^a   Speijer, Dave ^a   Berkhout, Ben ^a   Jeeninga, Rienk E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PROTEIN C JUN; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROVIRUS; T LYMPHOCYTE ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HIV LONG TERMINAL REPEAT; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-JUN; T-LYMPHOCYTES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84897094484     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.059642-0     Document Type: Article

References (49)

1. Berkhout, B. & Jeang, K. T. (1992). Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 66, 139-149.
2. Berkhout, B., Silverman, R. H. & Jeang, K. T. (1989). Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59, 273-282.
3. Centlivre, M., Sommer, P., Michel, M., Ho Tsong Fang, R., Gofflo, S., Valladeau, J., Schmitt, N., Thierry, F., Hurtrel, B. & other authors (2005). HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J Clin Invest 115, 348-358.
4. Centlivre, M., Sommer, P., Michel, M., Ho Tsong Fang, R., Gofflo, S., Valladeau, J., Schmitt, N., Wain-Hobson, S. & Sala, M. (2006). The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection. AIDS 20, 657-666.
5. Chen, B. K., Feinberg, M. B. & Baltimore, D. (1997). The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol 71, 5495-5504.
6. Crotti, A., Chiara, G. D., Ghezzi, S., Lupo, R., Jeeninga, R. E., Liboi, E., Lievens, P. M., Vicenzi, E., Bovolenta, C. & other authors (2007). Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes. Open Virol J 1, 26-32.
7. Dahabieh, M. S., Ooms, M., Malcolm, T., Simon, V. & Sadowski, I. (2011). Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter. Virology 418, 57-66.
8. Das, A. T., Klaver, B. & Berkhout, B. (1999). A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol 73, 81-91.
9. De Baar, M. P., De Ronde, A., Berkhout, B., Cornelissen, M., Van Der Horn, K. H., Van Der Schoot, A. M., De Wolf, F., Lukashov, V. V. & Goudsmit, J. (2000). Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res Hum Retroviruses 16, 499-504.
10. Donahue, D. A. & Wainberg, M. A. (2013). Cellular and molecular mechanisms involved in the establishment of HIV-1 latency. Retrovirology 10, 11-22.
11. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S. & Rabson, A. B. (1989). Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A 86, 5974-5978.
12. Duverger, A., Jones, J., May, J., Bibollet-Ruche, F., Wagner, F. A., Cron, R. Q. & Kutsch, O. (2009). Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 83, 3078-3093.
13. Duverger, A., Wolschendorf, F., Zhang, M., Wagner, F., Hatcher, B., Jones, J., Cron, R. Q., van der Sluis, R. M., Jeeninga, R. E. & other authors (2013). An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J Virol 87, 2264-2277.
14. Eferl, R. & Wagner, E. F. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3, 859-868.
15. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. & Fauci, A. S. (1989). Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 86, 2365-2368.
16. González, E., Punzón, C., González, M. & Fresno, M. (2001). HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J Immunol 166, 4560-4569.
17. Hess, J., Angel, P. & Schorpp-Kistner, M. (2004). AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117, 5965-5973.
18. Isel, C. & Karn, J. (1999). Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J Mol Biol 290, 929-941.
19. Jeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K. & Berkhout, B. (2000). Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 74, 3740-3751.
20. Jeeninga, R. E., Westerhout, E. M., van Gerven, M. L. & Berkhout, B. (2008). HIV-1 latency in actively dividing human T cell lines. Retrovirology 5, 37-50.
21. Kamine, J., Subramanian, T. & Chinnadurai, G. (1991). Sp1dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A 88, 8510-8514.
22. Koken, S. E., van Wamel, J. L. B., Goudsmit, J., Berkhout, B. & Geelen, J. L. M. C. (1992). Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191, 968-972.
23. Koken, S. E. C., van Wamel, J. L., Geelen, J. L. M. C. & Berkhout, B. (1994). Functional analysis of the ACTGCTGA sequence motif in the human immunodeficiency virus type-1 long terminal repeat promoter. J Biomed Sci 1, 83-92.
24. Malcolm, T., Kam, J., Pour, P. S. & Sadowski, I. (2008). Specific interaction of TFII-I with an upstream element on the HIV-1 LTR regulates induction of latent provirus. FEBS Lett 582, 3903-3908.
25. Marshall, N. F. & Price, D. H. (1995). Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J Biol Chem 270, 12335-12338.
26. Meng, Q. & Xia, Y. (2011). c-Jun, at the crossroad of the signaling network. Protein Cell 2, 889-898.
27. Montano, M. A., Novitsky, V. A., Blackard, J. T., Cho, N. L., Katzenstein, D. A. & Essex, M. (1997). Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 71, 8657-8665.
28. Nabel, G. & Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
29. Naghavi, M. H., Schwartz, S., Sonnerborg, A. & Vahlne, A. (1999). Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 15, 1293-1303.
30. Peden, K., Emerman, M. & Montagnier, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185, 661-672.
31. Pereira, L. A., Bentley, K., Peeters, A., Churchill, M. J. & Deacon, N. J. (2000). A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28, 663-668.
32. Rizzi, C., Crippa, M. P., Jeeninga, R. E., Berkhout, B., Blasi, F., Poli, G. & Alfano, M. (2006). Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1. J Immunol 176, 999-1006.
33. Roof, P., Ricci, M., Genin, P., Montano, M. A., Essex, M., Wainberg, M. A., Gatignol, A. & Hiscott, J. (2002). Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 296, 77-83.
34. Ross, E. K., Buckler-White, A. J., Rabson, A. B., Englund, G. & Martin, M. A. (1991). Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 65, 4350-4358.
35. Ruijter, J. M., Thygesen, H. H., Schoneveld, O. J., Das, A. T., Berkhout, B. & Lamers, W. H. (2006). Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 3, 2-10.
36. Sadowski, I. & Mitchell, D. A. (2005). TFII-I and USF (RBF-2) regulate Ras/MAPK-responsive HIV-1 transcription in T cells. Eur J Cancer 41, 2528-2536.
37. Sanders, R. W., de Jong, E. C., Baldwin, C. E., Schuitemaker, J. H., Kapsenberg, M. L. & Berkhout, B. (2002). Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J Virol 76, 7812-7821.
38. van der Sluis, R. M., Pollakis, G., van Gerven, M. L., Berkhout, B. & Jeeninga, R. E. (2011). Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter. Retrovirology 8, 73-85.
39. van der Sluis, R. M., Jeeninga, R. E. & Berkhout, B. (2013a). Establishment and molecular mechanisms of HIV-1 latency in T cells. Curr Opin Virol 3, 700-706.
40. van der Sluis, R. M., van Montfort, T., Pollakis, G., Sanders, R. W., Speijer, D., Berkhout, B. & Jeeninga, R. E. (2013b). Dendritic cellinduced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes. PLoS Pathog 9, e1003259.
41. Van Lint, C., Bouchat, S. & Marcello, A. (2013). HIV-1 transcription and latency: an update. Retrovirology 10, 67.
42. van Montfort, T., Thomas, A. A., Pollakis, G. & Paxton, W. A. (2008). Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans. J Virol 82, 7886-7896.
43. van Opijnen, T., Jeeninga, R. E., Boerlijst, M. C., Pollakis, G. P., Zetterberg, V., Salminen, M. & Berkhout, B. (2004a). Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J Virol 78, 3675-3683.
44. van Opijnen, T., Kamoschinski, J., Jeeninga, R. E. & Berkhout, B. (2004b). The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication. J Virol 78, 6883-6890.
45. Verhoef, K., Koper, M. & Berkhout, B. (1997). Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237, 228-236.
46. Verhoef, K., Sanders, R. W., Fontaine, V., Kitajima, S. & Berkhout, B. (1999). Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol 73, 1331-1340.
47. Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H. & Jones, K. A. (1998). A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462.
48. West, M. J., Lowe, A. D. & Karn, J. (2001). Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation. J Virol 75, 8524-8537.
49. Williams, S. A., Chen, L. F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E. & Greene, W. C. (2004). Prostratin antagonizes HIV latency by activating NF-kappaB. J Biol Chem 279, 42008-42017.